发明名称 |
TREATMENT METHOD USING EGFR ANTIBODIES AND SRC INHIBITORS AND RELATED FORMULATIONS EGFR SRC |
摘要 |
<p>The present invention relates to the treatment of EGFR-mediated disease, particularly cancer by inhibiting or blocking EGFR and src in combination or simultaneously. The invention relates to treatment, prevention, or modulation of cancer, particularly EGFR-mediated disease, with one or more EGFR modulator and src inhibitor in combination. The invention further relates to the treatment of cancer with anti-EGFR antibodies and src inhibitors. Methods and compositions for treatment of cancer with the antibody anti-EGFR mAb806 in combination or series with a src inhibitor or src inhibitors are described.</p> |
申请公布号 |
HK1139437(A1) |
申请公布日期 |
2015.12.18 |
申请号 |
HK20100106228 |
申请日期 |
2010.06.23 |
申请人 |
LUDWI INSTITUTE FOR CANCER RESEARCH LTD. |
发明人 |
CAVENEE, WEBSTER;FURNARI, FRANK;JOHNS, TERRANCE, GRANT;SCOTT, ANDREW |
分类号 |
C12P;A61K;A61P;C07K |
主分类号 |
C12P |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|